|1.||García-Sastre, Adolfo: 23 articles (04/2015 - 04/2002)|
|2.||Donis, Ruben O: 22 articles (09/2015 - 01/2006)|
|3.||Tumpey, Terrence M: 20 articles (01/2016 - 08/2002)|
|4.||Wilson, Ian A: 20 articles (09/2015 - 09/2005)|
|5.||Palese, Peter: 20 articles (12/2014 - 04/2002)|
|6.||Mettenleiter, Thomas C: 18 articles (03/2015 - 03/2006)|
|7.||Treanor, John J: 17 articles (10/2015 - 03/2006)|
|8.||Webster, Robert G: 17 articles (01/2015 - 02/2002)|
|9.||Compans, Richard W: 16 articles (05/2014 - 10/2007)|
|10.||Katz, Jacqueline M: 14 articles (11/2015 - 08/2002)|
|1.||Human Influenza (Influenza)
09/01/2014 - "Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes."
01/01/2012 - "Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice."
11/19/2013 - "Expression of recombinant hemagglutinin (rHA) in insect cells represents a technology with proven efficacy in seasonal influenza and with the potential for a rapid response to the emergence of new, pandemic strains. "
01/01/2011 - "According to our results, one to two amino acid changes (N125D and/or N156K) in the major antigenic sites of the hemagglutinin of influenza A(H1N1)2009 virus may lead to significant reduction in the ability of patient and vaccine sera to recognize A(H1N1)2009 viruses."
01/01/2011 - "By encoding an influenza virus (IFV) hemagglutinin (HA) HA1 domain, an Ad5-HA1 vector conferred rapid protection as a prophylactic drug followed by elicitation of sustained protective immunity as a vaccine for inducing seamless protection against influenza as a drug-vaccine duo (DVD) in a single package. "
01/01/2003 - "A correlation between the amount of hemagglutinin (HA) per dose of vaccine and the protection against clinical signs of disease and infection by A/Chicken/Italy/13474/99 highly pathogenic (HP) AI (HPAI) virus was established. "
04/01/1973 - "Depending upon the level of virus infection, antiviral activity was best observed at the daily dose of 75 mg/kg. The efficacy of the compound was evidenced by an increase in survivor number, prolongation of mean survival time, suppression of lung consolidation, or decrease in hemagglutinin titer in the infected lung samples. "
12/01/1985 - "Results of the efficacy field trial suggest protection against infection and symptomatic illness in children inoculated with ca H1N1, despite its failure to stimulate high levels of hemagglutinin-inhibiting antibody."
11/01/2014 - "Protective efficacy of a single dose of baculovirus hemagglutinin-based vaccine in chickens and ducks against homologous and heterologous H5N1 virus infections."
03/01/2014 - "The ferret model was used to assess the potential of hemagglutinin stalk-based immunity to provide protection against influenza virus infection. "
|3.||Influenza in Birds (Avian Flu)
01/06/2000 - "This recombinant fowlpox-H5 avian influenza hemagglutinin vaccine can provide protection against a variety of different highly pathogenic H5 avian influenza viruses and frequent optimizing of the hemagglutinin insert to overcome genetic drift in the vaccine may not be necessary to provide adequate field protection."
12/01/2003 - "Construction, genetic stability and protective efficacy of a recombinant fowlpox virus expressing hemagglutinin (HA) gene (rFPV-HA) of H5 subtype avian influenza virus were conducted. "
12/01/2003 - "[Construction, genetic stability and protective efficacy of recombinant fowlpox virus expressing hemagglutinin gene of H5N1 subtype avian influenza virus]."
12/01/2015 - "The results of the study shows that avian influenza viruses after multiple passages in different biological systems undergo mutations, in particular, the largest number of amino acid substitutions occurred in all biological substrates in the hemagglutinin. "
01/01/2015 - "In this study we demonstrated that the vaccine candidate against avian influenza virus H5N1 based on the hemagglutinin H5 (HA) fused to the chicken CD154 (HACD) can also be used for differentiating infected from vaccinated animals (DIVA). "
|4.||Whooping Cough (Pertussis)
07/01/1981 - "[Studies on a method for the assay of antibody to Bordetella pertussis fimbrial hemagglutinin after inoculation with pertussis HA vaccine (author's transl)]."
01/01/2011 - "pertussis filamentous hemagglutinin."
03/01/2006 - "pertussis virulence factor filamentous hemagglutinin in gammadelta TCR-/- mice. "
07/01/2005 - "For pertussis serosurveillance, an in-house ELISA for antipertussis-toxin (PT) and anti-filamentous-hemagglutinin (FHA) were established in our laboratory and compared by a Ball-ELISA which had been reported to be reliable previously. "
09/01/2001 - "pertussis surface components, one of which is the virulence factor filamentous hemagglutinin (FHA), contribute to the binding. "
01/01/1980 - "[The tetanus antibodies titer alterations evaluated by means of indirect hemagglutinin test (HAp) after specific and nonspecific stimulation (author's transl)]."
12/01/2015 - "Antibody responses to pertussis toxin (PT), filamentous hemagglutinin (FHA), fimbriae 2 + 3 (FIMs), diphtheria, tetanus, Hib, MCC and PCV13 serotypes were compared to responses in a historical cohort of 246 infants born to mothers not vaccinated in pregnancy. "
12/01/1992 - "We compared an acellular (B type) pertussis-component diphtheria-tetanus-pertussis (DTP-Ac) vaccine containing equal amounts of filamentous hemagglutinin and lymphocytosis-promoting factor with a conventional whole-cell vaccine as the first booster immunization in 162 healthy children 15 to 24 months of age. "
01/01/2012 - "Postbooster seroprotection (diphtheria, tetanus, inactivated poliovirus, polyribosyl-ribitol phosphate) and serconversion (pertussis toxoid, filamentous hemagglutinin) rates were high and similar in each group, and geometric mean antibody concentrations increased markedly in both groups. "
07/01/2009 - "Cord GMCs to diphtheria and tetanus were 0.16 and 1.06 IU/mL, respectively, and cord GMCs to pertussis toxin, filamentous hemagglutinin, and pertactin were 16.2, 34.8, and 17.7 ELISA U/mL (by ELISA), respectively. "
|5.||DNA (Deoxyribonucleic Acid)
|10.||Immunoglobulin G (IgG)
|2.||Home Nursing (Nursing, Home)
|4.||Transplantation (Transplant Recipients)